9 months to make a baby, a bit longer to sell Adheriums next generation sensors ?

Reflecting while enjoying a red wine night cap.
9 months since announcing manufacturing of the next gen Adherium sensor and still no patients, no orders, no sales, no revenue and no news.
Either no one wants it or no one knows how to sell it cos they keep telling us that the reimbursement path is open through RTM and RPM and they have signed up great partners who you would assume they know what they are doing?


Melbourne, Australia – 11 February 2022: Adherium Limited (ASX: ADR), a leader in respiratory eHealth, remote monitoring and data management solutions, is pleased to announce it has completed the first production run of the next generation Hailie® sensors with physiological parameters for monitoring Asthma and Chronic Obstructive Pulmonary Disease (COPD) medication use. Mr Rick Legleiter, Chief Executive Officer, commented, “commencing manufacturing of our new, next generation smart inhaler is an important milestone. This is another example of executing and delivering on our product roadmap. Bringing innovation to market and working with our business partners to implement and deliver value-based medicine is the path toward commercializing our product portfolio. As a respiratory innovator for over 20 years, Adherium has an unequalled and formidable track record of development and experience expected of a market leader in respiratory digital health.”